NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
March 9, 2004 • Volume 1 / Number 10 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Funding OpportunitiesFunding Opportunities

Join the Tour of Hope with Lance Armstrong

The Bristol-Myers Squibb Tour of Hope™ will champion the race toward a cure for cancer this fall, and you can be a part of it. Applications for joining the 20-member Bristol-Myers Squibb Tour of Hope™ Team will be available on March 15 at The Tour is an extraordinary bicycle ride across the country that will mobilize America to speed the search for a cure. Applications are due Sunday, April 4 at 11:59 pm EDT.

Pathogenesis and Treatment of Lymphedema and Lymphatic Diseases

Application Receipt Dates: June 1, 2004;
Oct. 1, 2004; Feb. 1, 2005; June 1, 2005; Oct. 1, 2005;
Feb. 1, 2006; June 1, 2006; Oct. 1, 2006

NCI invites qualified researchers to submit applications for research project grants to investigate the pathogenesis and new treatments for primary and secondary lymphedema. Research is also needed on the pathophysiology of the disorders of skin and subcutaneous tissue secondary to chronic lymphedema, as well as lymphedema that results from cancers and cancer treatment, with an ultimate goal to develop more targeted and effective therapies.

The PA will use the NIH individual research project grant (R01) award mechanism.

For more information see

Inquiries: Dr. Suresh Mohla,

In Vivo Cellular and Molecular Imaging Centers (ICMICs)

Letter of Intent Receipt Date: June 22, 2004; June 21, 2005
Application Receipt Dates: July 22, 2004; July 22, 2005

The NCI Cancer Imaging Program invites applications for new or competing P50 Research Center Grants for ICMICs. The 5-year P50 ICMIC grants described are designed to bring together interdisciplinary scientific teams to lead the nation in cutting-edge cancer molecular imaging research with clinical relevance, provide unique core facilities to support oncology imaging research, provide flexibility to respond to exciting pilot research opportunities, and provide interdisciplinary career development opportunities for investigators new to the field of molecular cancer imaging.

This PAR will use the NIH P50 Specialized Centers Grant Mechanism.

For more information see

Inquiries: Dr. Anne E. Menkens,